Arthrobacter woluwensis is an aerobic Actinobacteria that is commonly detected in the environment, particularly in soil. It is a prevalent member of the aerobic bacterial communities in soil samples. This bacterium is known for its low pathogenic potential, although it has been associated with infections in individuals with compromised immune systems.
To date, only six cases of bacteremia caused by Arthrobacter woluwensis have been documented in the scientific literature. The first known case was reported in 1996, involving a 33-year-old woman with HIV infection. Subsequent cases were reported in 2004, 2005, 2007, 2010, and 2016. All these patients had underlying medical conditions, including diabetes mellitus, chronic renal failure, liver cirrhosis, or malignancy. In most instances, the sources of the infection remained unidentified, with the exception of one case linked to a Port-A catheter.
The clinical outcomes for most cases were favorable, except for one patient who succumbed to septic shock. The average age of the individuals affected by Arthrobacter woluwensis bacteremia was approximately 57.5 years, with an age range spanning from 33 to 76 years. The gender distribution was relatively balanced, with three male and three female patients.
The standard duration of antibiotic therapy ranged from 14 to 28 days, with an average of 21.8 days.Commonly used antibiotics included vancomycin, teicoplanin, and ampicillin. Antimicrobial susceptibility testing revealed that Arthrobacter woluwensis displayed sensitivity to vancomycin and teicoplanin but was resistant to penicillin, cephalosporin, and ciprofloxacin.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus:Arthrobacter
Species:A. woluwensis
The cells of Arthrobacter woluwensis are relatively small, typically measuring between 0.5 to 1.5 micrometers in length and 0.5 to 0.8 micrometers in width. Colonies formed by A. woluwensis are also modest in size, with an average diameter of about 2 mm.During the growth phase, the cells of Arthrobacter woluwensis exhibit a rod-shaped morphology.
However, during the stationary phase, they tend to adopt a spherical or coccoid shape. Their cells feature a gram-positive cell wall characterized by a thick layer of peptidoglycan and the presence of teichoic acids. These components contribute to the structural integrity of the cell.
Arthrobacter woluwensis exhibits several strategies for survival and interaction with its environment. It can synthesize and accumulate glycogen, which enhances its fitness and persistence in aquatic environments.
Additionally, the bacterium employs invasion proteins that facilitate its entry into host cells, either by inducing endocytosis or by forming pores in the cell membrane. These invasion proteins play a critical role in evading the host immune system, gaining access to intracellular resources, and can also contribute to tissue damage and inflammation.
Furthermore, Arthrobacter woluwensis utilizes sialic acid, allowing it to mimic host structures, evade immune recognition, and serve as a source of nitrogen & carbon. One notable strain of Arthrobacter woluwensis, ATCC 700220, was initially isolated from a blood culture of a 33-year-old woman with HIV infection in Belgium.
The pathogenesis of Arthrobacter woluwensis remains relatively enigmatic, but several potential factors are believed to contribute to its behavior:
Arthrobacter woluwensis is adaptable and can persist in diverse environmental conditions, including soil, water, and air. Humans can come into contact with the bacterium through direct physical contact or inhalation.
The bacterium possesses urease, an enzyme capable of hydrolyzing urea into ammonia and carbon dioxide. This enzymatic activity raises the pH of the local environment, potentially leading to tissue damage.
Arthrobacter woluwensis exhibits resistance to certain common antibiotics, including penicillin, cephalosporin, and ciprofloxacin. This resistance can complicate the treatment of infections caused by this bacterium.
Additionally, there is evidence to suggest that A. woluwensis may evade the host immune response by forming biofilms. Biofilms are intricate communities of microorganisms attached to surfaces and shielded by a matrix of extracellular polymeric substances. These biofilms can provide protection and contribute to the persistence of the bacterium in the host.
The human host employs various mechanisms to combat Arthrobacter woluwensis bacteremia. One such mechanism involves the activation of mast cells, specialized immune cells that release histamine and other inflammatory mediators.
These mast cells play a crucial role in enhancing the killing of Arthrobacter woluwensis by phagocytes, such as macrophages and neutrophils, and they aid in recruiting additional immune cells to the infection site, bolstering the immune response.
Another defense mechanism against this bacterium is the production of nitric oxide, a gas molecule with potent antimicrobial and immunomodulatory effects. Nitric oxide serves to inhibit the growth and survival of Arthrobacter woluwensis.
Additionally, it regulates the expression of genes associated with host defense, contributing to the overall immune response against the bacterium. These two fundamental defense mechanisms underscore the multifaceted nature of the host’s response to Arthrobacter woluwensis infection, involving both cellular and molecular components.
Clinical manifestations of Arthrobacter woluwensis infection encompass a range of severe conditions:
Bacteremia:Arthrobacter woluwensis bacteremia is characterized by the presence of these bacteria in the bloodstream, leading to systemic inflammation. This condition may not present clear and distinct symptoms, but it can progress to septicemia, a life-threatening complication of infection. In some instances, bacteremia can manifest with symptoms like fever, chills, malaise, and fatigue, although it can often be subtle and challenging to diagnose.
Endocarditis:Arthrobacter woluwensis endocarditis represents an infection of the inner lining of the heart’s chambers & valves. This condition can give rise to various clinical manifestations, including the development of a new or exacerbated heart murmur, chest pain, shortness of breath, night sweats, unexplained weight loss, and splenomegaly, which refers to an enlarged spleen. Furthermore, endocarditis is associated with potential embolic complications, such as stroke, renal infarction, or the formation of mycotic aneurysms.
Diagnosing Arthrobacter woluwensis infections involves a combination of methods to ensure accuracy:
Culture test: In diagnostic culture tests for Arthrobacter woluwensis, selective media like MacConkey agar or blood agar may be used to encourage bacterial growth and isolate the organism. It forms small, circular, convex, and smooth colonies with a yellow-to-white color.
Biochemical Tests: Commercial kits like API Coryne, API 20 Strep, or Vitek 2 GP can be used for initial identification. However, it’s important to note that these kits may only sometimes provide reliable results, and some strains may exhibit atypical reactions. Therefore, additional biochemical tests, including catalase, oxidase, urease, and nitrate reduction, may be necessary to confirm the identification.
Phylogenetic Analysis: To distinguish Arthrobacter woluwensis from other Arthrobacter species, molecular methods like 16S rRNA gene sequencing can be employed. This approach reveals the genetic relatedness and evolutionary links between bacteria, making it the most accurate and dependable method for diagnosis.
Whole Genome Sequencing Analysis: Conducting a complete genome analysis of Arthrobacter woluwensis can provide insights into its genetic features, such as the presence of common subunits of the urease system. This in-depth genomic analysis can offer valuable information for a comprehensive understanding of the bacterium.
Avoid exposure to soil or dust that may contain the bacteria, especially if you have a weakened immune system or a heart condition. Minimize contact with potentially contaminated environments.
Practice good hand hygiene by washing your hands frequently and thoroughly with water & soap, particularly after handling plants or soil. This can help reduce the risk of Arthrobacter transmission.
Clean and disinfect any wounds or injuries that may come into contact with soil or dust. Prompt wound care can prevent potential infections.
Arthrobacter woluwensis is an aerobic Actinobacteria that is commonly detected in the environment, particularly in soil. It is a prevalent member of the aerobic bacterial communities in soil samples. This bacterium is known for its low pathogenic potential, although it has been associated with infections in individuals with compromised immune systems.
To date, only six cases of bacteremia caused by Arthrobacter woluwensis have been documented in the scientific literature. The first known case was reported in 1996, involving a 33-year-old woman with HIV infection. Subsequent cases were reported in 2004, 2005, 2007, 2010, and 2016. All these patients had underlying medical conditions, including diabetes mellitus, chronic renal failure, liver cirrhosis, or malignancy. In most instances, the sources of the infection remained unidentified, with the exception of one case linked to a Port-A catheter.
The clinical outcomes for most cases were favorable, except for one patient who succumbed to septic shock. The average age of the individuals affected by Arthrobacter woluwensis bacteremia was approximately 57.5 years, with an age range spanning from 33 to 76 years. The gender distribution was relatively balanced, with three male and three female patients.
The standard duration of antibiotic therapy ranged from 14 to 28 days, with an average of 21.8 days.Commonly used antibiotics included vancomycin, teicoplanin, and ampicillin. Antimicrobial susceptibility testing revealed that Arthrobacter woluwensis displayed sensitivity to vancomycin and teicoplanin but was resistant to penicillin, cephalosporin, and ciprofloxacin.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus:Arthrobacter
Species:A. woluwensis
The cells of Arthrobacter woluwensis are relatively small, typically measuring between 0.5 to 1.5 micrometers in length and 0.5 to 0.8 micrometers in width. Colonies formed by A. woluwensis are also modest in size, with an average diameter of about 2 mm.During the growth phase, the cells of Arthrobacter woluwensis exhibit a rod-shaped morphology.
However, during the stationary phase, they tend to adopt a spherical or coccoid shape. Their cells feature a gram-positive cell wall characterized by a thick layer of peptidoglycan and the presence of teichoic acids. These components contribute to the structural integrity of the cell.
Arthrobacter woluwensis exhibits several strategies for survival and interaction with its environment. It can synthesize and accumulate glycogen, which enhances its fitness and persistence in aquatic environments.
Additionally, the bacterium employs invasion proteins that facilitate its entry into host cells, either by inducing endocytosis or by forming pores in the cell membrane. These invasion proteins play a critical role in evading the host immune system, gaining access to intracellular resources, and can also contribute to tissue damage and inflammation.
Furthermore, Arthrobacter woluwensis utilizes sialic acid, allowing it to mimic host structures, evade immune recognition, and serve as a source of nitrogen & carbon. One notable strain of Arthrobacter woluwensis, ATCC 700220, was initially isolated from a blood culture of a 33-year-old woman with HIV infection in Belgium.
The pathogenesis of Arthrobacter woluwensis remains relatively enigmatic, but several potential factors are believed to contribute to its behavior:
Arthrobacter woluwensis is adaptable and can persist in diverse environmental conditions, including soil, water, and air. Humans can come into contact with the bacterium through direct physical contact or inhalation.
The bacterium possesses urease, an enzyme capable of hydrolyzing urea into ammonia and carbon dioxide. This enzymatic activity raises the pH of the local environment, potentially leading to tissue damage.
Arthrobacter woluwensis exhibits resistance to certain common antibiotics, including penicillin, cephalosporin, and ciprofloxacin. This resistance can complicate the treatment of infections caused by this bacterium.
Additionally, there is evidence to suggest that A. woluwensis may evade the host immune response by forming biofilms. Biofilms are intricate communities of microorganisms attached to surfaces and shielded by a matrix of extracellular polymeric substances. These biofilms can provide protection and contribute to the persistence of the bacterium in the host.
The human host employs various mechanisms to combat Arthrobacter woluwensis bacteremia. One such mechanism involves the activation of mast cells, specialized immune cells that release histamine and other inflammatory mediators.
These mast cells play a crucial role in enhancing the killing of Arthrobacter woluwensis by phagocytes, such as macrophages and neutrophils, and they aid in recruiting additional immune cells to the infection site, bolstering the immune response.
Another defense mechanism against this bacterium is the production of nitric oxide, a gas molecule with potent antimicrobial and immunomodulatory effects. Nitric oxide serves to inhibit the growth and survival of Arthrobacter woluwensis.
Additionally, it regulates the expression of genes associated with host defense, contributing to the overall immune response against the bacterium. These two fundamental defense mechanisms underscore the multifaceted nature of the host’s response to Arthrobacter woluwensis infection, involving both cellular and molecular components.
Clinical manifestations of Arthrobacter woluwensis infection encompass a range of severe conditions:
Bacteremia:Arthrobacter woluwensis bacteremia is characterized by the presence of these bacteria in the bloodstream, leading to systemic inflammation. This condition may not present clear and distinct symptoms, but it can progress to septicemia, a life-threatening complication of infection. In some instances, bacteremia can manifest with symptoms like fever, chills, malaise, and fatigue, although it can often be subtle and challenging to diagnose.
Endocarditis:Arthrobacter woluwensis endocarditis represents an infection of the inner lining of the heart’s chambers & valves. This condition can give rise to various clinical manifestations, including the development of a new or exacerbated heart murmur, chest pain, shortness of breath, night sweats, unexplained weight loss, and splenomegaly, which refers to an enlarged spleen. Furthermore, endocarditis is associated with potential embolic complications, such as stroke, renal infarction, or the formation of mycotic aneurysms.
Diagnosing Arthrobacter woluwensis infections involves a combination of methods to ensure accuracy:
Culture test: In diagnostic culture tests for Arthrobacter woluwensis, selective media like MacConkey agar or blood agar may be used to encourage bacterial growth and isolate the organism. It forms small, circular, convex, and smooth colonies with a yellow-to-white color.
Biochemical Tests: Commercial kits like API Coryne, API 20 Strep, or Vitek 2 GP can be used for initial identification. However, it’s important to note that these kits may only sometimes provide reliable results, and some strains may exhibit atypical reactions. Therefore, additional biochemical tests, including catalase, oxidase, urease, and nitrate reduction, may be necessary to confirm the identification.
Phylogenetic Analysis: To distinguish Arthrobacter woluwensis from other Arthrobacter species, molecular methods like 16S rRNA gene sequencing can be employed. This approach reveals the genetic relatedness and evolutionary links between bacteria, making it the most accurate and dependable method for diagnosis.
Whole Genome Sequencing Analysis: Conducting a complete genome analysis of Arthrobacter woluwensis can provide insights into its genetic features, such as the presence of common subunits of the urease system. This in-depth genomic analysis can offer valuable information for a comprehensive understanding of the bacterium.
Avoid exposure to soil or dust that may contain the bacteria, especially if you have a weakened immune system or a heart condition. Minimize contact with potentially contaminated environments.
Practice good hand hygiene by washing your hands frequently and thoroughly with water & soap, particularly after handling plants or soil. This can help reduce the risk of Arthrobacter transmission.
Clean and disinfect any wounds or injuries that may come into contact with soil or dust. Prompt wound care can prevent potential infections.
Arthrobacter woluwensis is an aerobic Actinobacteria that is commonly detected in the environment, particularly in soil. It is a prevalent member of the aerobic bacterial communities in soil samples. This bacterium is known for its low pathogenic potential, although it has been associated with infections in individuals with compromised immune systems.
To date, only six cases of bacteremia caused by Arthrobacter woluwensis have been documented in the scientific literature. The first known case was reported in 1996, involving a 33-year-old woman with HIV infection. Subsequent cases were reported in 2004, 2005, 2007, 2010, and 2016. All these patients had underlying medical conditions, including diabetes mellitus, chronic renal failure, liver cirrhosis, or malignancy. In most instances, the sources of the infection remained unidentified, with the exception of one case linked to a Port-A catheter.
The clinical outcomes for most cases were favorable, except for one patient who succumbed to septic shock. The average age of the individuals affected by Arthrobacter woluwensis bacteremia was approximately 57.5 years, with an age range spanning from 33 to 76 years. The gender distribution was relatively balanced, with three male and three female patients.
The standard duration of antibiotic therapy ranged from 14 to 28 days, with an average of 21.8 days.Commonly used antibiotics included vancomycin, teicoplanin, and ampicillin. Antimicrobial susceptibility testing revealed that Arthrobacter woluwensis displayed sensitivity to vancomycin and teicoplanin but was resistant to penicillin, cephalosporin, and ciprofloxacin.
Classification and Structure:
Kingdom: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus:Arthrobacter
Species:A. woluwensis
The cells of Arthrobacter woluwensis are relatively small, typically measuring between 0.5 to 1.5 micrometers in length and 0.5 to 0.8 micrometers in width. Colonies formed by A. woluwensis are also modest in size, with an average diameter of about 2 mm.During the growth phase, the cells of Arthrobacter woluwensis exhibit a rod-shaped morphology.
However, during the stationary phase, they tend to adopt a spherical or coccoid shape. Their cells feature a gram-positive cell wall characterized by a thick layer of peptidoglycan and the presence of teichoic acids. These components contribute to the structural integrity of the cell.
Arthrobacter woluwensis exhibits several strategies for survival and interaction with its environment. It can synthesize and accumulate glycogen, which enhances its fitness and persistence in aquatic environments.
Additionally, the bacterium employs invasion proteins that facilitate its entry into host cells, either by inducing endocytosis or by forming pores in the cell membrane. These invasion proteins play a critical role in evading the host immune system, gaining access to intracellular resources, and can also contribute to tissue damage and inflammation.
Furthermore, Arthrobacter woluwensis utilizes sialic acid, allowing it to mimic host structures, evade immune recognition, and serve as a source of nitrogen & carbon. One notable strain of Arthrobacter woluwensis, ATCC 700220, was initially isolated from a blood culture of a 33-year-old woman with HIV infection in Belgium.
The pathogenesis of Arthrobacter woluwensis remains relatively enigmatic, but several potential factors are believed to contribute to its behavior:
Arthrobacter woluwensis is adaptable and can persist in diverse environmental conditions, including soil, water, and air. Humans can come into contact with the bacterium through direct physical contact or inhalation.
The bacterium possesses urease, an enzyme capable of hydrolyzing urea into ammonia and carbon dioxide. This enzymatic activity raises the pH of the local environment, potentially leading to tissue damage.
Arthrobacter woluwensis exhibits resistance to certain common antibiotics, including penicillin, cephalosporin, and ciprofloxacin. This resistance can complicate the treatment of infections caused by this bacterium.
Additionally, there is evidence to suggest that A. woluwensis may evade the host immune response by forming biofilms. Biofilms are intricate communities of microorganisms attached to surfaces and shielded by a matrix of extracellular polymeric substances. These biofilms can provide protection and contribute to the persistence of the bacterium in the host.
The human host employs various mechanisms to combat Arthrobacter woluwensis bacteremia. One such mechanism involves the activation of mast cells, specialized immune cells that release histamine and other inflammatory mediators.
These mast cells play a crucial role in enhancing the killing of Arthrobacter woluwensis by phagocytes, such as macrophages and neutrophils, and they aid in recruiting additional immune cells to the infection site, bolstering the immune response.
Another defense mechanism against this bacterium is the production of nitric oxide, a gas molecule with potent antimicrobial and immunomodulatory effects. Nitric oxide serves to inhibit the growth and survival of Arthrobacter woluwensis.
Additionally, it regulates the expression of genes associated with host defense, contributing to the overall immune response against the bacterium. These two fundamental defense mechanisms underscore the multifaceted nature of the host’s response to Arthrobacter woluwensis infection, involving both cellular and molecular components.
Clinical manifestations of Arthrobacter woluwensis infection encompass a range of severe conditions:
Bacteremia:Arthrobacter woluwensis bacteremia is characterized by the presence of these bacteria in the bloodstream, leading to systemic inflammation. This condition may not present clear and distinct symptoms, but it can progress to septicemia, a life-threatening complication of infection. In some instances, bacteremia can manifest with symptoms like fever, chills, malaise, and fatigue, although it can often be subtle and challenging to diagnose.
Endocarditis:Arthrobacter woluwensis endocarditis represents an infection of the inner lining of the heart’s chambers & valves. This condition can give rise to various clinical manifestations, including the development of a new or exacerbated heart murmur, chest pain, shortness of breath, night sweats, unexplained weight loss, and splenomegaly, which refers to an enlarged spleen. Furthermore, endocarditis is associated with potential embolic complications, such as stroke, renal infarction, or the formation of mycotic aneurysms.
Diagnosing Arthrobacter woluwensis infections involves a combination of methods to ensure accuracy:
Culture test: In diagnostic culture tests for Arthrobacter woluwensis, selective media like MacConkey agar or blood agar may be used to encourage bacterial growth and isolate the organism. It forms small, circular, convex, and smooth colonies with a yellow-to-white color.
Biochemical Tests: Commercial kits like API Coryne, API 20 Strep, or Vitek 2 GP can be used for initial identification. However, it’s important to note that these kits may only sometimes provide reliable results, and some strains may exhibit atypical reactions. Therefore, additional biochemical tests, including catalase, oxidase, urease, and nitrate reduction, may be necessary to confirm the identification.
Phylogenetic Analysis: To distinguish Arthrobacter woluwensis from other Arthrobacter species, molecular methods like 16S rRNA gene sequencing can be employed. This approach reveals the genetic relatedness and evolutionary links between bacteria, making it the most accurate and dependable method for diagnosis.
Whole Genome Sequencing Analysis: Conducting a complete genome analysis of Arthrobacter woluwensis can provide insights into its genetic features, such as the presence of common subunits of the urease system. This in-depth genomic analysis can offer valuable information for a comprehensive understanding of the bacterium.
Avoid exposure to soil or dust that may contain the bacteria, especially if you have a weakened immune system or a heart condition. Minimize contact with potentially contaminated environments.
Practice good hand hygiene by washing your hands frequently and thoroughly with water & soap, particularly after handling plants or soil. This can help reduce the risk of Arthrobacter transmission.
Clean and disinfect any wounds or injuries that may come into contact with soil or dust. Prompt wound care can prevent potential infections.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
